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This paper discusses celebrity participation in social marketing programs focusing on public 
health, especially on HIV programs. The research identifies the inhibitions of celebrity people 
and implications that this involvement may have upon their lives. The paper analysis data 
from in-depth interviews made to twenty-seven Portuguese celebrities from arts, show 
business and sports. The results show absence of prejudice against HIV. Famous people feel 
motivated to join public health and HIV cause because of the serious nature of the disease, as 
well as the social stigma attached to AIDS which can suggest positive discrimination. The 
paper also shows that celebrities expected a fee for their endorsement, despite the social role 
they consider celebrities should have, and the positive image they benefit for endorsing public 
health campaigns. The research discusses celebrity expectations and worries and, finally, 
shows several results that are helpful for negotiations between institutions and celebrities 
insofar as it may pave the way for celebrity involvement in social marketing programs. 
 























1.  INTRODUCTION 
Celebrities can be important agents in the marketing process, namely in brand equity 
creation. Celebrity brand endorsements benefit the effectiveness of communication 
campaigns, as well as the celebrity own personal image, in a process of value co-creation 
(Seno and Lukas, 2007: 131). Their credibility and attractiveness usually promote the 
receptors’ social identification (Basil and Brown, 1997: 404-405). A similar process occurs 
with social messages. Health promotion campaigns are examples of social marketing 
programs which have been successful in influencing people’s behavior for the purpose of 
societal benefit (Morris and Clarkson, 2009: 2). Several celebrities have endorsed AIDS 
prevention campaigns, including Bono, Jeffrey Sachs and Paul Farmer, who founded the 
Global Fund on AIDS (Richey and Ponte, 2008: 716). The global HIV and AIDS epidemic, 
including the particular Portuguese epidemiological situation within the European context 
requires the involvement of everyone to control infection (UNAIDS, 2008: 32). Because of 
the initially diagnosed social context, HIV infection and AIDS are affected by attitudes and 
behaviors of stigma and discrimination (Kalichman et al., 2009: 87). These feelings have been 
reported by volunteers who help people living with HIV or take part in prevention actions 
(Omoto and Snyder, 2002: 852). 
Celebrity refusals to become involved in social marketing in HIV prevention led to the 
present research, which discusses celebrity participation in social marketing programs 
focusing on public health, especially on HIV, identifying both inhibitions and implications 
that this involvement may have upon their lives, professionally as well as personally. This 
research sought to ascertain whether famous people who had been involved in these initiatives 
bear evidence of such feelings and whether this fact could truly inhibit them from taking part 
in social marketing campaigns. 
 
 
2.  A BRIEF REVIEW OF RELEVANT LITERATURE 
 
2.1 Social Marketing  
Social marketing was proposed by Kotler and Zaltman in 1971 when they were researching 
marketing applications to problems of social change. They defined social marketing as “the 




social ideas and involving considerations of product planning, pricing, communication 
distribution and marketing research” (Kotler and Zaltman, 1971: 5). Later, Andreasen defined 
social marketing as “the application of commercial marketing technologies to the analysis, 
planning, execution and evaluation of programs designed to influence the voluntary behavior 
of target audience in order to improve their personal welfare and that of their society” (2003: 
296). This new definition of social marketing focuses on influencing people’s behavior 
instead of influencing people’s ideas (Andreasen, 1996; Brenkert, 2002: 15). The concept of 
social marketing is traditionally used in non-profit organizations and public sector but 
Andreasen argues the assumption of social marketing in the commercial sector (2003: 299).  
The first social marketing work was done in the sixties and involved public health issues, 
namely family planning in India, in 1964, which derestricted the amount of condoms 
distributed to people as well as reducing their price (Dholakia, 1984: 54-56). International 
public health programs introduced marketing techniques, namely by advertising contraceptive 
methods and condom placement assessment assurance in the media (Walsh et al., 1993: 108). 
Influencing life-styles to improve health leads to cost reductions in healthcare and treatments. 
That is why health professionals and institutions cannot limit themselves to therapies but have 
to help modify lifestyles and behaviors (Rothschild, 1999: 24).  
The effectiveness of social marketing in public health is recognized in the literature 
(Morris and Clarkson, 2009: 2). Nowadays, this area is the one where social marketing is 
most commonly discussed (Walsh et al., 1993: 111), not only through health promotion 
practices, but also with health assessment assurance and price reduction of products that have 
a social benefit. Social Marketing in public health has been successful in AIDS control 
(Chance and Deshpandré, 2009: 220-232), and in the development of third-world countries 
(Duhaime et al. 1985, pp.3-13). Public health campaigns require good message architecture 
and correct broadcasting through appropriate channels. The media is frequently used for this 
purpose (Abroms and Maibach, 2008: 221-227). 
 
2.2 Marketing and Celebrities 
A celebrity brand endorser is “an individual who enjoys public recognition and who uses 
this recognition on behalf of a consumer good by appearing with it in an advertisement” 
(McCracken, 1989: 310). Celebrities are seldom associated with their fame and credibility 
(Goldsmith, 2000: 43). This association process can be directed towards brands and activate 




McCracken, 1989: 310). This means that business can become more profitable with celebrity 
brand endorsement (Erdogan et al., 2001: 39), based on the fact that brands also contribute to 
the celebrities’ increased fame. Seno and Lukas (2007: 129) highlight brand equity reciprocity 
between celebrity image brand and commercial brand through a co-branding process which 
only happens when the relationship is based on credibility and attractiveness, both in person 
and product. Authors consider five factors in characterizing celebrity product associations: 
credibility, attractiveness, congruency, multiplicity and activation (Seno and Lukas, 2007: 
123-130). Despite the potential problems in celebrity endorsement, resulting from the risk of 
negative reputation sometimes targeting well-known people (Till and Shimp, 1998: 79-80), 
researchers have concluded that business is greatly favored in terms of financial return and 
brand equity (Agrawal and Kamakura, 1995: 60). 
The equity effect of product endorsement by celebrities also occurs in social marketing. 
Famous people are seen as social models especially by teenagers (Biskup and Pfister, 1999: 
199; Wicks et al., 2007: 403; White and O’Brien, 1999: 83). Celebrities are frequently used 
by social marketeers to promote behavior changes (Basil and Brown, 1997: 393). Their 
activism has been developed since the sixties with the purpose of solving social problems, 
such as poverty or disease (Huddart, 2005: 34; Richey and Ponte, 2008: 716;). George 
Harrison, Mick Jagger and Bob Geldof are examples of this activism, as are Bono, Oprah 
Winfrey, Mia Farrow, George Clooney and Don Cheadle (Huddart, 2005: 34; Richey and 
Ponte ,2008: 716; Waal, 2008: 46-47). 
The television ad where Magic Johnson admitted that he was HIV positive had a great 
impact on Americans (Basil and Brown, 1997: 395). Researchers refer Magic Johnson gave 
efficacy to HIV prevention messages because of the new image the infection gained after his 
statement - a problem that can affect heterosexuals. People’s identification with Magic 
Johnson promoted the increase of sexually safe behaviors (Basil and Brown, 1997: 406; 
Brown and Basil, 1995: 345; Kalichman and Hunter, 1992: 1376; Quadagno et al., 1997: 
359). This case suggests that celebrities can be an effective resource in promoting public 
health issues (Casey et al., 2003: 259). The same authors emphasize that the effects of a 
similar association do not have to be positive and depend on the type of messages, the social 
responsibility level and the identification process between the celebrity in question and the 






The Human Immunodeficiency Virus (HIV) was first diagnosed in 1981, in the United 
States of America, among homosexual men, leading the medical community to initially call it 
“GRIDS” - Gay-Related Immune Deficiency Syndrome (Clarke, 2006: 317). HIV was later 
diagnosed among heterosexuals from Haiti, injected drug users and hemophiliacs. Nowadays, 
HIV is a global epidemic that does not differentiate between gender, age, race or wealth. It is 
an important cause of disease and death which affects development, mainly in Africa. At the 
end of 2007, thirty-three million people were living with HIV around the world (UNAIDS 
2008: 32). 
The social context around the first HIV diagnosis made people who lived with the infection 
feel stigma and discrimination (Dias et al., 2006: 208; Herek, 1999: 1106; Johnny and 
Mitchell, 2006: 755; Kalichman et al., 2009: 87; Klein et al., 2002, p.44; Lee et al., 1999: 
300; Parker and Aggleton, 2003: 15; Taylor, 2001: 792; Valdiserri, 2002: 341).  HIV was 
associated with metaphors of plague, death, fear, guilt and shame (Ponte, 2004) and AIDS 
was seen as a punishment for homosexuality or behavior deviation (Clarke, 2006: 318). 
Furthermore, the mass media have perpetuated this speech, especially associating HIV 
vulnerability with homosexuals (Clarke, 2006: 318; Lupton et al., 1993; Ponte, 2004).  
It is true that, since the beginning of time, stigma and discrimination have walked side by 
side with illnesses in general, from syphilis to cholera or leprosy for instance (Valdisserri, 
2002: 341). Nowadays, fighting HIV stigma and discrimination is one of the main priorities 
proclaimed by the United Nations Organization (2001). People still believe in misconceptions 
about HIV transmission, which fuels the fear of being infected and, consequently, the fear of 
coming into contact with people who live with it (Dias et al., 2006: 208). 
Volunteers who participate in HIV prevention services also report feelings of stigma and 
discrimination from their social networks towards them (Omoto and Snyder, 2002: 852). A 
comparison between volunteers in HIV services and volunteers in intensive care services with 
cancer patients revealed that stigma reported by volunteers with similar roles was higher for 
those who cared for people living with HIV (Snyder et al., 1999: 1181-1183). The fact that 
volunteers involved in HIV prevention are “punished by their own good actions” may result 
in inhibition for those taking part in AIDS prevention campaigns, mainly those who have 
stronger social networks (Snyder et al., 1999: 1185-1186), even though society bestows added 





These and other inhibitions may also occur with famous people, due to the general public’s 
fear of any contact with the disease. This may be because celebrities such as Rock Hudson or 
Freddie Mercury were among the first in the world to be diagnosed with HIV. Magic Johnson 
took on those risks with the public announcement of his being positive. He was neither the 
victim of stigma nor did his image lose credibility. On the contrary, his problem served to 
emphasize that AIDS is not a disease of the guilty, but something that may happen to anyone 
anywhere in the world, from heterosexuals to famous people or even to heroes, as he was 
considered (Casey et al., 2003: 261). 
 
 
3.  METHODOLOGY 
 
Bearing in mind the effectiveness of celebrity participation in social marketing, such as 
Magic Johnson’s in HIV prevention campaigns, as well as being aware of the social stigma 
and discrimination towards HIV and AIDS, this paper aims to identify the inhibitions famous 
people may feel when endorsing this cause, and, at the same time, to discuss the professional 
as well as personal implications this involvement may have upon their lives.  
The research takes the form of a qualitative exploratory analysis using personal interviews, 
one of the most popular instruments of qualitative research (Carson et al., 2001:73), insofar as 
they allow for open data collection (Flick, 1999). Twenty-seven confidential and in-depth 
interviews were conducted between 1 June and 31 December 2008 with well-known 
Portuguese people from arts, show business and sports, with experience in social marketing in 
public health. These twenty-seven celebrities appear frequently in the Portuguese media, 
namely in television, VIP magazines and websites about celebrities. The interviewees are 
aged mainly between 31 and 50 years old (51.8%). 59% are women and 63% are 
actors/actresses. The selection of the interviewees was based on celebrities’ accessibility and 
availability for the research. The interviewed individuals involved in each of the fifteen 
categories of health problems identified in Table 1 that shows the diseases most endorsed by 










No. % People % Actions 
Blood Donation  1  3.7  1.3 
Breast Cancer  9  33.3  11.8 
Cardiovascular   6  22.2  7.9 
Children’s health  2  7.4  2.6 
Drugs Prevention  2  7.4  2.6 
HIV Infection  22  81.4  28.9 
Leukaemia/Cancer 12  44.4  15.8 
Lung Cancer  1  3.7  1.3 
Non-smoking   5  18.5  6.6 
Obesity, Diabetes  2  7.4  2.6 
Osteoporosis 6  22.2  7.9 
Renal Diseases  1  3.7  1.3 
Senior Health  2  7.4  2.6 
Tuberculosis 1  3.7  1.3 
Uterine Cancer   4  14.8  5.3 
Total of Actions  76  -----  100 
Interviewees 27  100  ----- 
Table 1 – Celebrity participation in health-related social marketing campaigns. 
 
The purpose was to understand the interviewees’ perceptions, motivations and inhibitions, 
as well as the consequences of endorsing HIV and AIDS prevention actions in their careers 
and personal lives. First of all, an interview guideline was created, as suggested by Miles and 
Huberman (1994), but flexibility was allowed in order to obtain further information from the 
experiences of the interviewees (McCracken, 1988). The interviews took approximately one 
hour each. This allowed for a valuable data collection process, which would not be possible in 
an enquiry.  
We proceeded to analyze the content of the interviews, creating answer categories as 
recommended (Carson et al., 2001: 83) and crossing data through the different control groups 
of interviewees. The control groups were established according to the following criteria: 
demographics, like age, sex and occupation; their own image perception as a celebrity; 
participation frequency and context; cause preference; social marketing experience focusing 
on HIV; opinion on celebrity roles and compensations; opinion on social marketing relevance; 
fear and general inhibitions to endorse causes; and experience of discrimination in the case of 
social marketing endorsement focusing on HIV prevention. These control groups were 




celebrities interviewed. A number was attributed to each celebrity without any logic order, so 
that the famous people interviewed would be assured confidentiality. 
 
 
4.  DISCUSSION 
 
4.1 Social marketing endorsement relevance  
Though literature registers an increase in celebrities’ use of marketing (Erdogan et al., 
2001: 39; Amos et al., 2008: 209), our interviewees are divided with regard to the frequency 
celebrities are called to endorse causes. Although most celebrities of this research (85%) 
believe famous people should endorse social causes because they have a social role, four 
people interviewed do not share this opinion, supporting the idea that this kind of involvement 
is part of an individual action linked to awareness and is not related to celebrity status. They 
add that this is the reason why it is not fair to criticize famous people who do not take part in 
social marketing, even though they recognize that well-known people may help in public 
health campaigns, as literature presents (Biskup and Pfister, 1999: 199; White and O’Brien, 
1999: 83; Wicks et al., 2007: 403). 
The interviewed celebrities shared the opinion, also discussed in the literature, that famous 
people who endorsed a given cause are expected to set a social example regarding the 
behaviors associated with said cause (Wicks et al., 2007: 403). As a result of this view 
interviewee no. 1 says “some celebrities are not in a position to be an example in public 
health, because of their way of life”. This idea reflects the importance that Seno and Lukas 
(2007: 123-130) attribute to fitting famous people to the object of the marketing program in 
which they take part. Celebrity endorsement implies risks and one of the most serious is that 
the famous person may be seen as unreliable by not setting an example (Agrawal and 
Kamakura, 1995: 60; Till and Shimp, 1998: 79-80). Concerned about this situation, 
interviewee no. 15 criticizes “If people were compensated, they would be professionally 




Given the general opinion on the social role of celebrities, the interviewees tend to uphold 




benefit commercial brands or are developed by government institutions: as interviewee no. 5 
says “I don’t like social marketing with a central focus on business or brand promotion”. In 
fact, those two interviewees who have been compensated for social marketing campaigns 
explain that said activity led to specific advantages for certain brands by promoting specific 
behavior changes, despite the societal benefit. Table 2 show most interviewees have involved 
in social marketing without a payment. In a total of 76 social marketing campaigns this 
research illustrates 96% were not compensated.  
 
Pro Bono Involvement  Compensated Involvement 
Social Marketing Actions 
No.  %  People % Actions No. % People  % Actions
Blood Donation  1  3.7  1.3  0  0.0  0.0 
Breast Cancer  9  33.3  11.8  0  0.0  0.0 
Cardiovascular   5  18.5  6.6  1  3.7  1.3 
Children’s health  2  7.4  2.6  0  0.0  0.0 
Drugs Prevention  2  7.4  2.6  0  0.0  0.0 
HIV Infection  22  81.4  28.9  0  0.0  0.0 
Leukaemia/Cancer 12  44.4  15.8 0 0.0  0.0 
Lung Cancer  1  3.7  1.3  0  0.0  0.0 
Non-smoking   4  14.8  5.3  1  3.7  1.3 
Obesity, Diabetes  1  3.7  1.3  1  3.7  1.3 
Osteoporosis 6  22.2  7.9  0  0.0  0.0 
Renal Diseases  1  3.7  1.3  0  0.0  0.0 
Senior Health  2  7.4  2.6  0  0.0  0.0 
Tuberculosis 1  3.7 1.3  0  0.0  0.0 
Uterine Cancer   4  14.8  5.3  0  0.0  0.0 
Total of Actions  73  -----  96.0  3  -----  3.9 
Interviewees 25  92.6  -----  2  7.4  ----- 
Table 2 – Pro bono and compensated celebrity participation in social marketing. 
 
Although most interviewees believe that celebrities should not be paid for social 
marketing endorsement, which is seen as part of their social role, they emphasize that the pro 
bono concept should not be exclusive to well-known people. They add that all those taking 
part in pro bono campaigns should do the work without payment, not only celebrities. 
However, the interviewees sustain that when a campaign has a budget and contemplates the 
salaries of those involved, it should also compensate the famous people making the 




accepted. Celebrities began endorsing causes for no fees and now those who want to be 
compensated are frowned upon” (interviewee no. 18). 
Table 3 shows the interviewees’ opinion on service compensation in social marketing. 
Resistance to endorsing social marketing promoted by the State is explained by the existence 
of a government budget for health promotion campaigns which includes most payments of 
participants’ salary, namely directors and crew members. In this case, one would expect that 
the celebrity’s fees would also be respected or, in exchange, that any tax benefits would be 
attributed to the celebrity in question. 
 
Opinion on compensation in social marketing endorsements   No. of 
people 
 “Celebrities should be paid.”  2 
 “Celebrities should not be paid”  13 
 “Celebrities should not be paid, unless cause benefits commercial brands”   8 
 “Celebrities should not be paid, unless cause benefits commercial brands. 




Table 3 – Opinions on service fees in social marketing endorsements. 
 
4.3 Celebrity endorsed activities  
The celebrities interviewed had done something on health promotion, even if it took place 
a long time ago, or even if it had no notoriety. Twenty-two celebrities out of twenty-seven 
(81.4%) recall at least one social marketing endorsement focusing on HIV. Celebrity 
involvement in this issue is interesting because of the social stigma and discrimination 
associated with HIV and AIDS (Parker and Aggleton, 2003: 15). Celebrity selection was 
conducted based on health-related social marketing endorsement experience and not 
necessarily on their participation in social marketing campaigns focusing on HIV.  
HIV infection, leukemia and breast cancer are the topics with the most activities endorsed 
by celebrities, bearing evidence of the personal relationships between famous celebrities and 
these diseases. Thirteen of the interviewed celebrities mention a special motivation to 
participate in certain topics because of their personal relationship with these causes – “Cancer 
first, because I have suffered from it.  Motivation is total.” (interviewee no. 6). Although most 
celebrities state that their motivation does not vary with changing health themes (59.2%), they 




“Cancer can happen to anyone” (interviewee no. 9); “For cancer there is no warning and it has 
nothing to do with behaviors” (interviewee no. 13); HIV is a problem of behaviors and can be 
prevented, so I think I can do something about it” (interviewed no. 18). 
Among famous people, television professionals are those who present the most diversity in 
health-related social marketing endorsement, immediately followed by actors. This fact may 
be linked to the reliable image these professionals usually have in the eyes of the public, but it 
may also underline the fact that celebrity credibility is one of the most important factors when 
choosing people for marketing endorsement (Goldsmith, 2000: 43; Seno and Lukas, 2007: 
125). 
 
4.4 Social marketing endorsement contexts 
Social marketing endorsements occur as a consequence of an unusual invitation from an 
institution or as the result of a close relationship between famous people and the organization 
that is developing the activity. The literature reveals several examples of celebrities motivated 
to endorse a cause because of a close relationship with it. These include the case of Magic 
Johnson, with the AIDS prevention campaigns (Basil and Brown, 1997; Casey et al., 2003; 
Clarke, 2006), or George Harrison, helping children in Bangladesh because of a friend from 
that country, Mick Jagger with the concert on behalf of the earthquake victims in Nicaragua - 
where his wife was from - (Huddart, 2005: 34) and Don Cheadle, with his involvement in the 
Darfur conflict after his performance in the movie Hotel Rwanda (Waal, 2008: 46).  
Some contexts allow for social marketing endorsement, while others only raise obstacles. 
The main encouraging contexts reported by interviewees as encouraging them to participate 
tend to be the seriousness of the cause, the possibility of preventing the disease and the impact 
on people’s lives. The main impediment is agenda unavailability, message inadequacy, the 
possibility of economics or politics benefitting from the campaign and the unreliable nature of 
the institution involved. 
 
4.5 Inhibitions  
Apart from context obstacles, there is also the celebrity’s psychological inhibition in 
endorsing certain social marketing programs. Most celebrities interviewed to participate in 
health-related social marketing, and especially focusing on AIDS prevention programs, have 




undress publically, when contact with suffering was required or even if they felt that the 
public would identify them with the disease: "I would not endorse a cause if it obliged me to 
reveal my body unreasonably” (interviewee no. 5); “I would not enjoy talking about my 
private life as a behavior example” (interviewee no. 25); “There are issues that make me sad. I 
prefer not to endorse that kind of marketing campaign” (interviewee no. 3). 
 
The social stigma and discrimination around HIV, as well as the fact that some HIV 
positive celebrities have taken part in prevention campaigns – following the steps of Magic 
Johnson (Casey et al., 2003), could, ultimately affect famous people‘s availability to endorse 
the cause, due to their image brand management issues. This research shows that the most of 
the interviewees deny this possibility, which is consistent with the higher number of 
individuals interviewed with experience in HIV prevention actions: “I did not have any 
inhibition, on the contrary, I consider is necessary to talk about these issues and break away 
from  all the taboos there are in society about this” (interviewee no. 20); “We have to face 
HIV as a health problem and not with moral judgments about individuals’ choices” 
(interviewee no 16). 
Two celebrities interviewed reported a specific inhibition when participating in social 
marketing programs focusing on HIV and AIDS. One of them (interviewee no. 3) explains 
that he/she had personal problems regarding direct contact with suffering, a fact that is not 
exclusive to HIV prevention campaigns, since it exists in other topics of public health. 
Another celebrity cites fear of being associated with HIV positivity, a fact which could affect 
endorsement of the cause (interviewee no. 5). The latter point, regarding the public’s 
confusion was also quoted by another celebrity as a possibility (interviewee no. 26), even 
though it would not affect his/her participation in HIV prevention programs. This person 
thinks that the public truly believes that celebrities taking part in HIV prevention programs 
may be HIV positive. The possibility of public confusion does not deter this person from 
taking part in these initiatives.  
 
4.6 Celebrities’ life implications  
The vast majority of the interviewees state that they do not benefit professionally as a 
consequence of social marketing endorsements, or as a consequence of HIV and AIDS 
prevention interventions. However, they tend to admit that their personal image is improved. 




and not the basis of motivation to do so, although the literature mentions that notoriety 
ambition could become a motivation to take part in social marketing activities (Ferreira et al., 
2008: 49). Table 4 shows the opinion distribution on life implications, diverging from the 
research of Omoto and Snyder (2002) in relation to the perceptions about stigma reported by 
volunteers in HIV/AIDS prevention services.  
 
No. of people  Celebrities’ life implications related to social marketing 
endorsement  Yes No 
Did it promote professional opportunities?  6  21 
Did it improve your personal image among the public?  16  11 
TOTAL 27 
Table 4 – Opinions on celebrities’ life implications related to social marketing endorsement. 
 
The five interviewees without experience in HIV prevention actions concluded that their 
involvement in health campaigns promoted a better image of themselves among the target-
public, as shown in Table 5. Out of the twenty-two famous people who have participated in 
HIV prevention campaigns, eleven also concluded that their public image improved, therefore 
confirming the theory of value co-creation between the social marketing product and 
celebrities as well as the experience of Magic Johnson when he endorsed the HIV prevention 
campaign as someone who was HIV positive (Basil and Brown, 1997: 395; Casey et al., 
2003: 261). The other eleven famous people interviewed with AIDS prevention experience 
reported irrelevant associations from the public. These results suggest absence of theme 
specificity on HIV, comparing with other public health diseases, what is not according to the 
analysis about the risks celebrity take when they endorse stigmatized causes (Casey et al., 
2003: 261).  
Public Image perceptions  according to social marketing involvement by celebrities
Interviewees with experience in 
social marketing focused on 
HIV prevention  
Interviewees without experience 
in social marketing focused on 
HIV prevention 
TOTAL 
Indifferent   11  Indifferent   0  11 
Positive   11  Positive   5  16 
Negative   2   Negative   0  2  




The two famous people interviewed who report negative perceptions from specific types of 
public, who are not necessarily their main fans, also report a positive perception of their 
image from their target public. These negative associations include, in their opinion, direct 
connotations with being HIV positive. However, these feelings do not lead to any inhibition 
regarding future participations in this topic: "People think I may have engaged in risk 
behaviors, because of my lifestyle, and associate me with AIDS, but I am not afraid and I 
carry on endorsing these activities” (interviewee no. 22); “People follow an actor’s life and 
they approach me with concerns about the characters I perform. I believe the public thought 




5.  CONCLUSION 
 
Results from twenty-seven interviews with Portuguese celebrities, all of whom had 
social marketing experience in public health issues, suggest absence of theme specificity 
as well as absence of prejudice against HIV. The serious nature of the disease as well as 
the social stigma attached to AIDS is what motivates them to join the cause. It can mean 
positive discrimination. The target-public’s feeling of direct connotation with being 
HIV positive is only residual among the famous people who have taken part in these 
campaigns, and does not lead to any inhibition regarding future participations. The 
interviewees consider that these campaigns do not result in more professional 
opportunities, but concede that by participating they may create a positive image of 
celebrities. However, despite the social role they think famous people have, some of the 
interviewees believe that, in some cases, these services should be compensated, namely 
when these initiatives are promoted by companies or by the Government and when 
other professionals are paid in the same initiative. 
 
 
6.  FURTHER RESEARCH AND LIMITATIONS 
 
The information gathered may prove helpful in future negotiations between institutions and 
celebrities insofar as it may pave the way for celebrity involvement in social marketing 




related to social marketing endorsement, as well as their expectations and worries. On the 
other hand, celebrities also gather information which may explain their decision to take part in 
these initiatives or not. 
 
As an exploratory study, this research presents results which are limited to the celebrities 
interviewed. Although including confidential interviewees was considered the best method for 
this research, insofar as it allowed us to obtain valuable information from famous people 
regarding this issue, we must also admit that the interviews could possibly have inhibited the 
interviewees from verbalizing certain delicate aspects. Future research could explore this 
issue regarding the absence of social discrimination towards HIV and AIDS from famous 
people, as well as the possible existence of positive discrimination on that point. It could 
prove useful to compare this study’s results with a research conducted on a larger group of 
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￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿% ￿￿￿￿￿￿￿￿￿￿￿￿￿( ￿￿￿ ￿￿￿￿￿￿￿￿￿ 2 ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿3 ￿￿
& ’ 6 ￿ ￿ ￿ ￿ ￿& ￿ ￿ 2 ￿ ’ = ￿ ￿￿& ￿ ￿ ’ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿  ￿ ￿ 0 ￿1 ￿ ￿ ￿ - ￿ ￿ ’ ￿ ￿& ￿ ￿ ￿ ￿ ’ ￿￿￿. ￿￿￿￿￿￿￿￿￿￿￿ ￿￿: ￿￿￿￿￿( ￿￿’ ￿
￿ ￿- ￿￿￿￿￿ ￿￿￿￿￿￿￿% ￿. ￿￿ ￿￿￿￿& ￿￿￿￿￿,￿￿￿￿￿￿￿￿￿ 2 ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿3 3 ￿
￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿& ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿! ￿ ￿ ￿￿￿￿& ￿￿￿￿￿￿￿% ￿￿￿ ￿￿
& ￿￿￿￿& ￿￿￿￿￿￿￿’ ￿￿ ,+ ￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ 2 ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿3 ￿￿
￿￿ ￿ ￿ ￿. ￿ ￿ ￿ ￿ ￿ ￿￿, ￿ ( ￿ ￿ ￿￿ - ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿? ￿ ￿ ￿ ￿ ’ ￿1 ￿ ￿ ￿ ￿ ￿ ￿￿￿) ￿￿￿￿￿& ￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
￿￿￿￿￿￿￿￿￿￿￿￿#￿￿ ￿6￿￿￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿( ￿￿￿￿￿￿￿￿ 2 ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿3 ￿ ￿ & ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿& ￿ ￿ ’ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿￿￿￿￿￿￿￿￿￿ ￿/￿ ￿￿￿￿￿￿￿￿#￿￿￿ ￿￿ ￿& & ￿￿￿￿￿￿￿￿￿￿ 2 ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿3 ￿ ￿
  ￿ ￿ 0 ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿+ ￿ ￿ $ ￿ ’ 2 ￿ ￿ ￿￿ ￿ ￿ ￿# ￿ ￿ ’ ￿ ￿1 " ￿￿ " ￿1 ￿ ￿ ￿ ￿ ￿￿￿. ￿) ￿￿￿￿￿￿￿. ￿￿￿￿￿￿￿ ￿￿’ ￿￿￿; ￿￿￿￿ ￿￿￿￿￿￿￿￿
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￿ ￿ ’ ￿ 4￿ ￿ ￿ ￿+ ￿ ￿ ( ￿ ￿ ￿￿ ￿ ￿ ￿  ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿’ ￿￿￿￿￿( ￿- ￿￿￿￿￿- ￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿( ￿￿￿￿￿￿￿￿’ ￿
& ￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿￿% ￿￿￿￿￿#￿￿￿￿￿￿￿￿￿￿’ ￿￿￿’ ￿￿￿ ￿￿￿￿￿￿ ￿’ ￿￿￿￿￿5 ( ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿￿ ￿
￿￿ ￿ ￿ ￿. ￿ ￿ ￿ ￿ ￿ ￿￿, ￿ ( ￿ ￿ ￿￿ - ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿? ￿ ￿ ￿ ￿ ’ ￿1 ￿ ￿ ￿ ￿ ￿ ￿￿￿" ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿< ￿￿￿￿￿￿￿￿￿￿￿￿￿#￿￿ ￿￿￿￿￿
￿￿￿￿￿￿￿￿￿￿￿￿￿6￿￿￿& ￿￿￿￿￿￿& & ￿￿￿￿￿ ￿￿￿5 ( ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿% ￿
￿ ￿ ￿ ￿# ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿  ￿ ! ￿ ￿& ￿ ￿ ￿ ￿ ￿ ￿ <￿ ￿ <1 ￿ ’ 2 ￿ ￿￿ ￿ ￿ ￿7 ￿ ￿ ￿ ￿ ￿ ￿; ￿ ￿ ￿ ￿ ￿ ’ ￿￿￿! ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿
#￿￿￿ ￿￿￿$ ￿￿#￿￿- ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿5 ( ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿) ￿
# ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿￿ * ￿ ￿ ￿ ￿+ ￿ ’ ￿￿￿. ￿￿￿￿￿￿￿ & ￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿ ￿￿& ￿￿￿￿￿￿￿￿￿’ ￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿; ￿- /
+ = ￿￿& ￿￿￿￿￿! ￿ ￿ ￿,￿￿￿￿￿￿￿1 ￿ @ ￿ ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿￿￿
& ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿1 ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿￿￿ ￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
￿￿￿￿￿& ￿￿￿￿￿￿￿￿ ￿& > ￿9 ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿ ￿￿￿￿￿￿￿1 ￿ @ ￿ ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿3 ￿
￿￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿7 ￿ ￿ ￿ ￿ ￿￿ " ￿￿￿ ￿ ￿ ￿ ￿5 ’ ￿ 2 ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿( ￿￿& & ￿￿￿￿￿ ￿￿￿
￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿( ￿￿￿￿￿￿’ ￿￿% ￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿ #￿￿￿￿￿￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿￿1 ￿ @ ￿ ￿ 4￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿￿￿ ￿ ￿ ￿ ￿1 ￿ - ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ; ￿ ￿ ￿ > ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ( ￿ ￿￿ ￿ ￿ ￿; ￿ ’ ￿ ￿ ￿ ￿1 ￿ ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿￿￿￿￿? ￿￿￿￿￿￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿￿￿￿￿￿7 ￿￿￿￿￿￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿￿￿￿￿0 ￿4 ￿￿￿￿￿￿￿- ￿￿￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿2 ￿￿￿￿￿￿￿￿
& ￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿￿ ￿
￿ ￿ A ￿ ￿ ’ ￿￿ ’ 4￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿1 ￿ ’ 2 ￿ ￿￿ ￿ ￿ ￿. ￿ ￿ ￿ ￿ ￿1 ￿ ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿/￿. ￿￿￿￿￿￿￿@ ￿￿￿￿￿￿
’ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿+ ￿& ￿￿￿ ￿￿￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿￿ ￿
& ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ 1 ￿ * ￿ ￿; ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿1 ￿ - ￿ ￿ ￿1 ￿ ’ 2 ￿ ￿￿￿+ ￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿. ￿￿￿￿￿￿￿￿. ￿￿￿￿￿
￿￿￿+ ￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿0 ￿9 ￿￿￿￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿￿￿￿? ￿ ￿￿￿￿￿￿7 ￿￿￿￿! ￿￿￿,￿￿￿￿￿￿￿ ￿￿- ￿￿￿￿￿￿￿
￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿￿ ￿
￿ ￿ ’ ￿ @ ￿ ￿￿ " ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿" ￿: ￿ ’ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿: " ￿: ￿ ￿ ￿ ￿ ￿ ￿￿￿+ ￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿% ￿9 ￿￿￿
￿￿1 ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿2 ￿￿￿￿￿￿￿￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿￿
￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿# ￿ ￿ ￿ ￿ ￿ ￿￿￿4 ￿￿￿￿￿￿￿￿￿￿￿. ￿￿￿￿ ￿- ￿￿￿￿￿ ￿￿￿￿￿￿+ ’ ’ ￿￿￿￿￿￿( % ￿* ￿#￿+ ’ ’ ￿￿￿￿￿￿￿￿ ￿￿
4 ￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿ ￿￿￿￿￿￿￿A￿￿￿ ￿￿ ￿& ￿￿￿￿￿ ￿- ￿￿￿￿) ￿￿￿￿0 ￿￿￿  ￿ ’ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿ ￿
  ￿ ￿ ￿ ￿ ￿￿ ’ 4￿ ￿ ￿ 2 ￿ ￿ ￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿ ￿￿￿ ￿￿￿￿￿￿￿￿’ ￿
￿￿￿#￿￿$ ￿% ￿￿￿￿￿￿￿￿￿￿￿￿￿( ￿￿￿ ￿￿￿￿￿￿￿  ￿ ’ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ % ￿
# ￿ ￿ ￿ ￿ ￿￿￿ * ￿ ￿ ￿ ￿+ ￿ ’ ￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿, ￿ ( ￿ ￿ ￿￿ - ￿ ￿ ￿ ￿ ￿￿￿+ = ￿￿￿￿- ￿￿￿￿￿￿ ￿￿￿￿￿
￿ ￿￿￿￿￿- ￿￿￿￿￿￿#￿￿￿ ￿￿ ￿￿￿￿￿￿￿￿￿ ￿￿￿ ￿￿￿￿￿￿￿ ￿ ￿￿￿￿￿￿￿  ￿ ’ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ) ￿
￿ ￿ 4￿ ￿ ￿ ￿ ￿1 ￿ ’ 2 ￿ ￿￿￿ ￿ ￿ ￿# ￿ ￿ ’ ￿ ￿￿ - ￿ ￿ ( ￿ ￿ ￿ ￿￿ ￿ ￿ ￿, ￿ ( ￿ ￿ ￿￿ - ￿ ￿ ￿ ￿ ￿￿￿A￿ ￿￿￿ ￿￿ ￿￿￿￿￿￿￿￿￿￿’ ￿￿￿￿￿￿￿￿￿
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿0 ￿￿ ￿ ￿￿￿￿& ￿￿￿￿￿￿￿￿￿’ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿8 & ￿￿￿￿￿￿￿￿￿  ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿￿
1 ￿ - ￿ ￿ ￿￿ " ￿1 " ￿7 " ￿& ￿ ￿ ￿ ￿ ￿ ￿￿  ￿ ! ￿ ￿& ￿ ￿ ￿ ￿ ￿ ￿ <￿ ￿ <1 ￿ ’ 2 ￿ ￿￿ ￿ ￿ ￿# ￿ ￿ ( ￿ ’ ￿￿￿ ￿ ￿ ￿ ￿ ￿￿￿￿ ￿ ￿￿￿￿￿￿/& ￿￿￿& ￿ ￿￿( ￿
￿￿￿￿￿￿#￿￿￿ ￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿  ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ 3 ￿
￿￿ ￿ ￿ ￿ ￿1 ￿ - ￿ ￿ ￿￿ " ￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿7 ￿ ’ ￿ ’ ￿ ￿￿ " ￿￿" ￿￿" ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " ￿& " ￿& " ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿
￿! ￿￿￿￿￿￿￿￿￿￿￿￿￿  ￿￿￿￿￿￿( ￿" ￿￿#￿￿$ ￿￿￿￿￿￿￿￿+ ￿￿￿￿￿( ￿￿’ ￿￿ ￿￿￿￿￿￿￿￿  ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿￿
, ￿ ( ￿ ￿ ￿￿ - ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿￿ ￿ ￿ ￿ ￿. = ￿ 4@ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿( ￿￿ ￿￿￿￿￿￿￿￿￿< ￿￿ ￿￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿
￿ $ ￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿ @ ￿ ￿ ’ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿ ￿
￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿# ￿ ￿ ￿ ￿ ’ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿￿￿9 ￿- ￿￿￿￿￿￿￿￿￿￿￿￿￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿
￿￿￿￿￿￿￿￿￿( ￿￿￿￿￿￿￿￿￿% ￿￿￿￿￿￿￿￿￿￿￿￿￿& ￿￿￿￿￿( ￿& ￿￿￿& ￿￿￿￿￿￿￿￿￿￿ @ ￿ ￿ ’ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿ ￿
# ￿ ￿ ’ ￿ ￿1 ￿ ￿ 4￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ! ￿ ￿￿￿" ￿8 ￿￿) ￿￿￿￿￿￿￿￿￿￿. ￿￿￿￿￿￿" ￿￿#￿￿$ ￿% ￿￿ ￿ ￿￿+ ’ ’ ￿￿￿￿￿
￿’ ￿￿￿￿￿￿￿￿￿￿￿ & ￿￿￿￿￿￿￿￿￿￿￿￿. ￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿ @ ￿ ￿ ’ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿ ￿
￿￿ ￿ ( ￿ ￿￿￿ ￿ ￿ ￿ ’ ￿ ￿ ￿￿ ￿ ￿ ￿# ￿ ￿ ’ ￿ ￿1 ￿ ￿ 4￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿& ￿￿￿￿￿! ￿￿￿￿￿￿￿￿￿< ￿. ￿( ￿￿￿￿￿￿￿￿￿ ￿’ ￿￿￿￿￿￿￿￿￿
￿￿￿￿￿ ￿￿￿￿￿￿￿￿/￿ ￿￿￿’ ￿￿￿￿￿￿￿￿ @ ￿ ￿ ’ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿￿
￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿  ￿ ￿ 0 ￿1 ￿ A ￿ ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿￿￿￿￿￿￿￿’ ￿
￿￿! ￿ ￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿% ￿￿￿- ￿- ￿￿￿￿￿￿￿￿￿￿￿& & ￿￿￿￿￿ ￿￿￿￿￿ ￿ ( = ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿ ￿
  ￿ ￿ 0 ￿1 ￿ A ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿￿. ￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿’ ￿￿￿￿￿￿￿￿’ ￿! ￿ ￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿- ( ￿
￿￿& & ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿￿￿￿￿￿#￿￿$ ￿% ￿￿￿ ￿￿￿￿￿￿￿￿’ ￿￿ " + ￿ ￿ ￿￿ ￿￿￿￿￿￿￿￿￿ ￿ ( = ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ % ￿
  ￿ ! ￿ ￿; ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿￿￿ ￿ ￿ ￿ ’ ￿￿" ￿￿ " ￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿# ￿ ￿ ’ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿￿￿ ￿& ￿￿￿￿￿￿￿% ￿￿ ￿ ￿￿￿ ￿￿￿￿’ ￿￿￿
+ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿ ( = ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ) ￿
B ￿ ￿ ￿ ￿ ￿+ ￿ 4￿ ￿ ￿￿ ￿ ￿1 ￿ ’ 2 ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿￿￿￿￿￿￿￿￿￿#￿￿ 0 ￿. ￿
& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿? ￿￿￿￿￿￿￿￿￿( ￿￿￿￿￿￿￿￿￿￿￿￿& ￿￿7 ￿￿￿￿￿￿￿￿￿￿< ￿B C D C /
E F F G ￿￿￿￿￿ ￿ ( = ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿￿
￿6 ￿ ￿ ￿ ￿￿ " ￿# " ￿￿" ￿1 ￿ ’ 2 ￿ ￿￿￿. ￿,￿￿￿￿￿￿’ ￿) ￿￿#￿￿ ￿#￿￿￿ ￿￿ ￿￿￿￿￿￿￿& ￿￿￿￿￿5 ￿￿#￿￿￿￿￿￿+ 8 ￿￿￿￿￿￿￿￿￿￿￿< ￿
. ￿￿￿￿￿￿￿￿￿#￿￿￿ ￿￿ ￿￿￿￿￿& ￿￿￿￿￿￿￿￿￿5 ￿￿#￿￿￿￿￿￿+ 8 ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿ ( = ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ 3 ￿
￿￿ ￿ ￿ ￿ ￿ ￿ ￿; ￿ @ ￿ ￿ ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿ " & " ￿. ￿ ￿ / ￿ ￿ ￿ ￿ ￿￿￿4 & ￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿’ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿( ￿￿￿￿￿￿￿& ￿￿￿￿￿￿￿￿￿( ￿￿￿￿￿ ￿ ( = ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿￿
B ￿ ￿ ￿ ￿ ￿+ ￿ 4￿ ￿ ￿￿ ￿ ￿1 ￿ ’ 2 ￿ ￿￿￿￿ ￿& ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿< ￿B C D D /
E F F G ￿￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
￿￿￿￿￿ ￿ ￿
  ￿ ￿ ￿ ￿ ￿￿" ￿1 " ￿: ￿ ’ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿ ￿￿ " ￿￿ " ￿￿￿ ￿ ￿ ￿ ￿ ￿ ￿￿￿ ’ ￿ C ￿1 ￿ ￿ ￿ = ￿￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿ " ￿￿ " ￿1 " ￿￿ ’ 2 ￿ ￿ ￿￿￿) ￿￿￿￿￿￿￿
￿￿￿￿￿￿￿￿ ￿￿￿’ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿#￿￿￿ ￿= ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿ ￿￿ ￿ ￿ ￿￿
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￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
￿￿￿ ￿￿ ￿￿￿￿￿￿￿￿￿￿ ￿ ￿ ￿￿￿￿￿￿￿￿￿￿￿￿￿